Login to Your Account

Transition Raises $11M in Private Placement

By Catherine Shaffer
Staff Writer

Friday, August 2, 2013
Transition Therapeutics Inc. will receive an investment of up to $21 million from certain shareholders purchasing 2.5 million units of the company's stock at $4.19 per share. The financing will support the company through completion of three Phase II studies. Transition has compounds in development for Alzheimer's disease and bipolar disorder, and for Type II diabetes and obesity.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription